Italy

  1. Showing 5 results for:
  2. Italy
All Regions

Paediatric pre-clinical and basic research services

Provided by EPTRI

EPTRI

EPTRI provides integrated services for research developments through its five Thematic Research Platforms according to their specific research area of expertise:
1. PAEDIATRIC MEDICINES DISCOVERY, which relates to the early-stage discovery and development of druggable molecular targets specific to paediatric disease, as well as discovery of new drugs specific for the paediatric population.
2. PAEDIATRIC BIOMARKERS, performing research to identify, characterise and validate new biomarkers for diagnosis, prognosis and personalised therapy in paediatric diseases; provide access to/deposit of annotated paediatric biological samples.
3. DEVELOPMENTAL PHARMACOLOGY, concerning studies on the pharmacological characteristics of drugs and related body response, based on the knowledge of growth and development/maturation of the organs and functions
4. PAEDIATRIC MEDICINES FORMULATIONS, which develops appropriate age-specific formulations and adequate delivery systems for preterm neonates, infants, toddlers, children and adolescents.
5. PAEDIATRIC MEDICAL DEVICES to cover the gap in medical devices tailored for children addressing the changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies.

Visit website

Metabolomics facility

Provided by OASI - Open Access Service Infrastructure

METABOLOMICS FACILITY (Free or charged)
With the Metabolomics facility you can explore the metabolic profiles of your samples, identify the most interesting variation between conditions, and see the metabolic flux in action. The Metabolomics Facility includes:
*A complete metabolomics platform (GC-QTOF, LC-QTOF, and specific software)
*Seahorse XF24 Analyzer
*YSI 2950D Biochemistry Analyzer
Each instrument is available for specific and diverse analyses, from deep metabolomics analysis to simpler indication about the most important metabolic species (e.g. lactate, oxygen, glutamine, etc.).

Visit website

Services for research, clinical trials and technology transfer

Provided by CIDSTEM - INTERDEPARTMENTAL CENTRE FOR STEM CELLS AND REGENERATIVE MEDICINE

unimore

CIDSTEM has a GMP-authorized facility for the implementation of advanced therapies and the technical and professional skills to manage the GMP laboratory and clinical trials of these therapies.
It therefore possesses the know-how and instrumentation necessary to offer companies:
-an implementation service for research and clinical trials, approved by regulatory bodies, of advanced therapies involving cell cultures in GMP;
-A consulting service for the technological transfer of clinical and preclinical trials in GMP and for the production of cell cultures for advanced therapies.
-An implementation service of research aimed at the industrialization of cell cultures for the development of ATMPs;
-a testing service of new technologies (nanomaterials, scaffolds for the realization of 3D cellular tissues, laboratory equipment, software for clinical trials and for the management of biological data, GMP compliant logistics, etc.).

Translated with www.DeepL.com/Translator (free version)

Visit website

European Rare Disease Registry Infrastructure

Provided by EUROPEAN PLATFORM ON RARE DISEASE REGISTRATION (EU RD PLATFORM)

EC

The European Rare Disease Registry Infrastructure (ERDRI) renders rare disease registries’ data searchable and findable. This is achieved through the provision of following components: European Directory of Registries (ERDRI.dor), Central Metadata Repository (ERDRI.mdr) and Pseudonymisation Tool.

Visit website

Advice on paediatric research conducted in the basic, pre-clinical and translational setting.

Provided by EPTRI

EPTRI

The EPTRI centralised services are provided by experts involved in the EPTRI Central Hub:

1.Providing access to paediatric patients’ cohorts.
2. Providing access to paediatric samples and related data.
3. Advice on in-vivo / in-silico nonclinical study design.
4. Advice on in-vivo / in-silico clinical study design.
5. Advice and Document preparation for regulatory and ethic procedures.
6. Advice on preparing HTA reports for paediatric medicines, diagnostic and MDs.
7. Advice on Data and sample sharing preparation.
Supporting application to (public and private) funding opportunities.

Visit website